Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
|
|
Adverum Biotechnologies, Inc. (ADVM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/30/2022 |
SC 13D/A
| Sonic Fund II, L.P. reports a 4.6% stake in Adverum Biotechnologies, Inc. |
| 04/16/2021 |
SC 13D/A
| Sonic Fund II, L.P. reports a 6.8% stake in Adverum Biotechnologies, Inc. |
| 04/09/2021 |
SC 13D/A
| Sonic Fund II, L.P. reports a 6.8% stake in Adverum Biotechnologies, Inc. |
| 12/23/2020 |
SC 13D/A
| Versant Ventures IV, LLC reports a 5.1% stake in Adverum Biotechnologies, Inc. |
| 08/20/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/03/2019 |
SC 13D/A
| Sonic Fund II, L.P. reports a 6% stake in Adverum Biotechnologies, Inc. |
|
|